Safety and Efficacy of TULY (Rasburicase) in Prevention and Treatment of Malignancy-associated Hyperuricemia
Clinical trial NCT00921375 · COMPLETED
Trial details
- NCT number
- NCT00921375
- Sponsor
- Virchow Group
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2011-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.